Biochemical characterization of a phospholipase A2 homologue from the venom of the social wasp Polybia occidentalis
Wasp venoms constitute a molecular reservoir of new pharmacological substances such as peptides and proteins, biological property holders, many of which are yet to be identified. Exploring these sources may lead to the discovery of molecules hitherto unknown. This study describes, for the first time in hymenopteran venoms, the identification of an enzymatically inactive phospholipase A2 (PLA2) from the venom of the social wasp Polybia occidentalis.
P. occidentalis venom was fractioned by molecular exclusion and reverse phase chromatography. For the biochemical characterization of the protein, 1D and 2D SDS-PAGE were performed, along with phospholipase activity assays on synthetic substrates, MALDI-TOF mass spectrometry and sequencing by Edman degradation.
The protein, called PocTX, was isolated using two chromatographic steps. Based on the phospholipase activity assay, electrophoresis and mass spectrometry, the protein presented a high degree of purity, with a mass of 13,896.47 Da and a basic pI. After sequencing by the Edman degradation method, it was found that the protein showed a high identity with snake venom PLA2 homologues.
This is the first report of an enzymatically inactive PLA2 isolated from wasp venom, similar to snake PLA2 homologues.
KeywordsWasp Polybia occidentalis PocTX PLA2 homologue
Bovine serum albumin
Matrix-assisted laser desorption/ionization mass spectrometry
B. moojeni myotoxin II
Polybia occidentalis venom PLA2
Sodium dodecyl sulfate
The phospholipases commonly found in wasp venoms are PLA1, PLA2 and PLB, which are involved in diverse adverse effects during envenoming [1, 2, 3]. Phospholipases A2 (PLA2s) are abundant in the pancreatic juice of mammals and in snake and insect venoms . In bees, this enzyme is the main allergen of the venom, constituting 10-12% of their dry weight [5, 6]. However, this situation is not true for wasp venoms that can present 0.1-1% protein [7, 8]. Few PLA2s have been isolated and characterized from wasps, being restricted to incomplete sequences and phospholipase activity on synthetic substrates .
These enzymes hydrolyze membrane phospholipids, releasing fatty acids and lysophospholipids as products of the reaction, resulting in the production of lipid mediators, tissue damage and cell death [10, 11]. Disruption of biological membranes by these proteins depends on highly conserved areas among secreted PLA2s, such as the Ca2+-binding loop, the distribution of disulfide bridges and the presence of a histidine residue at position 48 . However, Lys49 PLA2s or homologues from Viperidae snake venoms can disrupt cell membranes and cause myonecrosis through mechanisms that are independent of their catalytic activity [12, 13]. The identification of isoforms of this protein in other organisms, not belonging to group IIA of secreted snake PLA2s, shows new gaps regarding the evolutionary process of Lys49 PLA2 homologues.
The social wasp Polybia occidentalis is endemic in neotropical regions, and is find in almost all Brazilian states [14, 15]. However, few studies have reported the isolation of its molecules. In this study we describe, for the first time, the isolation and characterization of an enzymatically inactive PLA2 from Polybia occidentalis venom, called PocTX, with high identity with snake venom PLA2 homologues.
The venom of the social wasp Polybia occidentalis was kindly provided by Dr. Marta Chagas Monteiro from the Institute of Health Sciences, Federal University of Pará (UFPA). The ethical aspects related to this project were appropriately approved by the Ethics Committee on Animal Use (protocol no. 2012/1), the Ethics Committee of FCFRP-USP (protocol no. 102/2009) and received the Certificate of Presentation for Ethical Appreciation (CAAE: 14204413.5.0000.0011).
Isolation and biochemical characterization
The crude venom of P. occidentalis (100 mg) was solubilized in 50 mM ammonium bicarbonate buffer, pH 8.0, and subjected to size exclusion chromatography in a Sephacryl S200 FF column (1 cm × 40 cm) attached to a GE Akta Purifier HPLC system in an isocratic gradient. The eluted fractions were frozen, lyophilized and tested for phospholipase activity. The fractions of interest were subjected to reverse phase chromatography using a C18 column (25 cm × 4.6 mm, 5 μm, Supelco Discovery) pre-equilibrated with a solution of 0.1% trifluoroacetic acid (TFA) (eluent A) and a linear gradient from 0 to 70% of 99.9% acetonitrile (ACN) and 0.1% TFA (eluent B).
Protein purity was assessed by 1D and 2D polyacrylamide gel electrophoresis with sodium dodecyl sulfate (SDS-PAGE) [16, 17]. Protein quantitation was based on the Bradford method (BioRad) using bovine serum albumin (BSA) as a standard. The gel employed to determine the relative mass of proteins by 1D SDS-PAGE used a discontinuous format at 12.5% under denaturation and reducing conditions. Samples were preheated at 100 °C for 3 min and applied to the wells along with the molecular weight standard (7-175 kDa, BioLabs P7709S). In the electrophoretic run, a current of 15 mA per gel was set along with free voltage for 1 h and 20 min. The gel was stained with Coomassie Blue G-250 and scanned in a GE Image Scanner III.
The 2D electrophoresis consisted of two steps: isoelectric focusing and 1D SDS-PAGE. For the first dimension, the sample was prepared in a rehydration solution (8 M urea, 2% CHAPS, 0.5/2% IPG buffer, 0.002% bromophenol blue and 1 M DTT); this same solution was then incubated with a 7-cm strip (pH 3-10, non-linear) for 12-20 h. After rehydration, the strip was applied to an Ettan IPGphor 3 (GE Healthcare) isoelectric focusing system and later stored at − 80 °C. For the second dimension, the strip was washed with DTT and iodoacetamide diluted in 5 mL of equilibration buffer solution (6 M urea, 2% SDS, 30% glycerol, 50 mM Tris-HCl, pH 7.4, 0.002% bromophenol blue), each. Then, the strip was applied to a 15% polyacrylamide gel. The gel was stained with Coomassie Blue G-250 and scanned in a GE Image Scanner III.
Phospholipase activity on 4N3OBA
The procedure was performed according to Petrovic et al.  with modifications. The phospholipase activity was determined using a solution of 4-nitro-3-octanoyloxy-benzoic acid (4N3OBA) (Enzo Life Sciences, USA) as substrate diluted in 10 mM Tris-HCl buffer pH 8.0, 10 mM CaCl2 and 100 mM NaCl and kept refrigerated until it was used. For the activity assay, 190 μL of the reagent 4N3OBA was combined with 10 μL of sample (1 mg/mL) (venom and/or fractions), and immediately incubated in a microplate spectrophotometer (Biotek Eon) at 37 °C. The absorbance was measured at 425 nm for 30 min with kinetic intervals of 1 min. Distilled water and Bothrops jararacussu venom were used as controls. The results were submitted to variance analysis followed by Dunnett’s posttest with p < 0.05. Bothrops jararacussu snake venom was obtained from the serpentarium BioAgents (Batatais, SP, Brazil).
Obtaining the molecular mass by mass spectrometry
In order to obtain protein molecular masses, a matrix-assisted laser desorption/ionization mass spectrometer (MALDI) with two TOF analyzers (AXIMA TOF-TOF Shimadzu) was used operating in linear mode using sinapinic acid as the ionization matrix. Insulin (5734.5 Da), cytochrome C (12,361.9 Da), apomyoglobin (16,952.2 Da), aldolase (39,212.2 Da) and albumin (66,430.0 Da) were used as calibrants.
N-terminal sequencing using Edman degradation
N-terminal sequencing of the isolated protein was performed using the Edman degradation technique. The sequence was determined by aPPSQ-33A automated sequencer (Shimadzu, Japan) and later subjected to a similarity search using BLAST software, with subsequent multiple alignment through UniProt.
For the isolation of PocTX, two chromatographic steps were used: molecular exclusion and reverse phase intercalated with phospholipase activity assays of the collected fractions. After rechromatography of the fractions of interest, a protein with a molecular mass of 13,896.47 Da, devoid of enzymatic activity and with high identity with snake venom Lys49 PLA2 homologue, was isolated. Sequence analysis showed a high identity (> 98%) with myotoxin II (MjTX-II) from B. moojeni, differing only in the insertion of a glutamic acid residue between residues 5 and 6. Residues conserved in PLA2 homologues like Leu5, Gln11, Asn28, Arg34, Lys49, Lys53 and Thr56 are present, along with the cysteine residues in positions 27, 29, 44, 45, 50, 51 and 58 .
Some studies have reported the purification of PLA2s from wasp venoms, for example: polybitoxins (PbTX I, II, III and IV), glycosylated and highly hemolytic heterodimers with 115-132 kDa  from Polybia paulista venom; the glycosylated and hemolytic agelotoxin (AgTX), isolated in three states of aggregation – 14, 42 and 74 kDa – from Agelaia pallipes pallipes venom ; and two PLA2s from P. paulista venom, with masses of 17,906 and 22,016 Da, one of which shows the presence of glycosylation sites .
PocTX is distinct from other PLA2s isolated from wasps and Hymenoptera venoms (Asp49 PLA2s or enzymatically active) since it showed no identity with proteins isolated and described for this order to date. PLA2s found in bees, scorpions, lizards, jellyfish and some human sources are classified within group III of secreted PLA2s . These proteins are phylogenetically distinct from groups I and II (which include snake PLA2s), but show high similarity in the Ca2+-binding loop and the catalytic site region [4, 20], demonstrating that despite having distinct primary sequences, they retain extremely important regions for the implementation of their biological functions.
In a proteomic analysis of the venom of the ant Solenopsis invicta, identified several groups of proteins, such as allergens (described for Hymenoptera), PLA2s and proteins similar to other animal toxins such as myotoxins, neurotoxins and cytolytic toxins from snakes, arthropods and anemones, respectively . Another study developed by Bouzid et al.  demonstrated that the transcriptome of the venom glands of Tetramorium bicarinatum presented more than 70% of sequences/transcripts encoded in the list of those not found in databases as well as protein sequences “not belonging to hymenoptera” with similarity to other animal toxins. Similar results were found by Liu et al.  who identified in the venom of the killer wasp Vespa velutina transcripts/sequences of putative toxins present in snakes and spiders, like C-type lectins and neurotoxins with presynaptic action and activity on ion channels. This demonstrates that many organisms may share components regarded as impassable among phylogenetically distinct species.
PLA2s from snakes and hymenopterans are involved in many pathophysiological effects in the event of envenoming. Myotoxic, neurotoxic and hemolytic activities and hemostatic and kidney disorders have been reported [8, 24, 25, 26, 27, 28, 29, 30]. The diversity of functions and the presence of different isoforms and phospholipases in hymenopteran venoms show that these proteins are essential for the maintenance of vital functions of these insects. This information is corroborated by Torres et al. , who, by means of the giant ant Dinoponera quadriceps’s transcriptome, identified the expression of various isoforms of PLA1, PLA2, PLD and PLB in their venom glands. PLD has not yet been described for hymenopteran venoms.
The isolation of a protein in wasp venoms with similarity with snake venom toxins shows how many gaps remain to be filled in the evolution of animal toxins. There is a variety of underexplored natural sources, proportional to the variety of molecules not yet isolated. PocTX not only allows for new questions about the evolutionary processes that bring such different organisms together, but also leads to inquiries about its involvement in Hymenoptera envenoming.
This study describes the isolation and physicochemical characterization of PocTX, the first enzymatically inactive PLA2 from wasp venom. The protein was purified by two chromatographic steps, intercalated by SDS-PAGE and enzymatic activity. PocTX presented high identity with snake venom Lys49 PLA2 homologues, representing a good strategy in understanding the mechanism of action of PLA2 homologues in such different venoms.
The authors would like to thank the Program for Technological Development in Tools for Health-PDTIS-FIOCRUZ for the use of its facilities.
The present study was supported by the National Council for Scientific and Technological Development (CNPq), the Coordination for the Improvement of Higher Education Personnel (CAPES), the Funding Authority for Studies and Projects (FINEP), and the State of Rondônia Research Foundation (FAPERO).
RDS, AMK, CASC, RSS, LSMD biochemically and functionally characterized. RDS, AMK, CASC, RSS, LSMD, LAC, JPZ, RGS, AMS conducted all experiments, analyzed and discussed the results obtained. RDS, AMK, CASC, RSS, LSMD, FPG, LAC, JPZ, RGS, AMS participated in the analysis and discussion of the results, performed a critical revision of the work and assisted in the writing and structuring of the article. RDS, AMK, RGS, LAC, AMS was responsible for the design of the work, supervised all experiments and drafted the manuscript. All authors read and approved the final manuscript.
The present study was approved by the Ethics Committee on Animal Use (protocol no. 2012/1), the Ethics Committee of FCFRP-USP (protocol no. 102/2009) and received the Certificate of Presentation for Ethical Appreciation (CAAE: 14204413.5.0000.0011). Moreover, the research was also approved by the Brazilian Institute of Environment and Renewable Natural Resources (IBAMA – license number 27131-1).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 13.Andrião-Escarso SH, Soares AM, Rodrigues VM, Angulo Y, Díaz C, Lomonte B, et al. Myotoxic phospholipases A2 in Bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu. Biochimie. 2000;82(8):755–63.CrossRefPubMedGoogle Scholar
- 14.Mortari MR, Cunha AOS, Carolino ROG, Coutinho-Netto J, Tomaz JC, Lopes NP, et al. Inhibition of acute nociceptive responses in rats after i.c.v. injection of Thr6-bradykinin, isolated from the venom of the social wasp, Polybia occidentalis. Br J Pharmacol. 2007;151(6):860–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Santos LD, Pieroni M, Menegasso ARS, Pinto JRAS, Palma MS. A new scenario of bioprospecting of hymenoptera venoms through proteomic approach. J Venom Anim Toxins incl Trop Dis. 2011;17(4):364–77. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992011000400003 Google Scholar
- 19.Angulo Y, Olamendi-Portugal T, Alape-Girón A, Possani LD, Lomonte B. Structural characterization and phylogenetic relationships of myotoxin II from Atropoides (Bothrops) nummifer snake venom, a Lys49 phospholipase A2 homologue. Int J Biochem Cell Biol. 2002;34(10):1268–78.CrossRefPubMedGoogle Scholar
- 28.Serrano SM, Reichl AP, Mentele R, Auerswald EA, Santoro ML, Sampaio CA, et al. A novel phospholipase A2, BJ-PLA2, from the venom of the snake Bothrops jararaca: purification, primary structure analysis, and its characterization as a platelet-aggregation-inhibiting factor. Arch Biochem Biophys. 1999;367(1):26–32.CrossRefPubMedGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.